BLVRA and Alzheimer disease: Atorvastatin increased BLVRA protein level and activity in the parietal cortex, followed by the increase of UCB, with a negative (protective) correlation with oxidative stress markers and cognition [70], confirming the intimate link between AD, redox stress, and the YPs.